Literature DB >> 19339247

Activation-induced degradation of FLIP(L) is mediated via the phosphatidylinositol 3-kinase/Akt signaling pathway in macrophages.

Bo Shi1, Tri Tran, Rudina Sobkoviak, Richard M Pope.   

Abstract

Cellular FLIP (Flice-like inhibitory protein) is critical for the protection against death receptor-mediated cell apoptosis. In macrophages, FLIP long (FLIP(L)) and FLIP short (FLIP(S)) mRNA was induced by tumor necrosis factor (TNF) alpha, mediated through NF-kappaB. However, we observed TNFalpha reduced the protein level of FLIP(L), but not FLIP(S), at 1 and 2 h. Similar results were observed with lipopolysaccharide. The reduction of FLIP(L) by TNFalpha was not mediated by caspase 8, or through JNK or Itch, but was suppressed by inhibition of the phosphatidylinositol 3-kinase/Akt pathway employing chemical inhibitors, a dominant negative Akt-1, or Akt-1 small interfering RNA. The reduction of FLIP(L) resulted in the short term induction of caspase 8-like activity, which augmented NF-kappaB activation. A co-immunoprecipitation assay demonstrated that Akt-1 physically interacts with FLIP(L). Moreover, TNFalpha enhanced FLIP(L) serine phosphorylation, which was increased by activated Akt-1. Serine 273, a putative Akt-1 phosphorylation site in FLIP(L), was critical for the activation-induced reduction of FLIP(L). Thus, these observations document a novel mechanism where by TNFalpha facilitates the reduction of FLIP(L) protein, which is dependent on the phosphatidylinositol 3-kinase/Akt signaling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339247      PMCID: PMC2682900          DOI: 10.1074/jbc.M807918200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  68 in total

Review 1.  The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling.

Authors:  Luke A J O'Neill; Andrew G Bowie
Journal:  Nat Rev Immunol       Date:  2007-05       Impact factor: 53.106

Review 2.  The role of macrophages in rheumatoid arthritis.

Authors:  Yingyu Ma; Richard M Pope
Journal:  Curr Pharm Des       Date:  2005       Impact factor: 3.116

3.  Caspase-8 prevents sustained activation of NF-kappaB in monocytes undergoing macrophagic differentiation.

Authors:  Cédric Rébé; Séverine Cathelin; Sophie Launay; Rodolphe Filomenko; Laurent Prévotat; Coralie L'Ollivier; Emmanuel Gyan; Olivier Micheau; Steven Grant; Anne Dubart-Kupperschmitt; Michaëla Fontenay; Eric Solary
Journal:  Blood       Date:  2006-10-17       Impact factor: 22.113

4.  Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases.

Authors:  Hideaki Kamata; Shi-Ichi Honda; Shin Maeda; Lufen Chang; Hajime Hirata; Michael Karin
Journal:  Cell       Date:  2005-03-11       Impact factor: 41.582

5.  Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail.

Authors:  Minna Poukkula; Aura Kaunisto; Ville Hietakangas; Konstantin Denessiouk; Tuire Katajamäki; Mark S Johnson; Lea Sistonen; John E Eriksson
Journal:  J Biol Chem       Date:  2005-05-10       Impact factor: 5.157

6.  Akt inhibition upregulates FasL, downregulates c-FLIPs and induces caspase-8-dependent cell death in Jurkat T lymphocytes.

Authors:  S M Uriarte; S Joshi-Barve; Z Song; R Sahoo; L Gobejishvili; V R Jala; B Haribabu; C McClain; S Barve
Journal:  Cell Death Differ       Date:  2005-03       Impact factor: 15.828

7.  Mcl-1 is essential for the survival of synovial fibroblasts in rheumatoid arthritis.

Authors:  Hongtao Liu; Polikseni Eksarko; Vladislav Temkin; G Kenneth Haines; Harris Perlman; Alisa E Koch; Bayar Thimmapaya; Richard M Pope
Journal:  J Immunol       Date:  2005-12-15       Impact factor: 5.422

8.  Requirement for caspase-8 in NF-kappaB activation by antigen receptor.

Authors:  Helen Su; Nicolas Bidère; Lixin Zheng; Alan Cubre; Keiko Sakai; Janet Dale; Leonardo Salmena; Razqallah Hakem; Stephen Straus; Michael Lenardo
Journal:  Science       Date:  2005-03-04       Impact factor: 47.728

9.  Genetic inactivation of RelA/p65 sensitizes adult mouse hepatocytes to TNF-induced apoptosis in vivo and in vitro.

Authors:  Fabian Geisler; Hana Algül; Stephan Paxian; Roland M Schmid
Journal:  Gastroenterology       Date:  2007-03-21       Impact factor: 22.682

10.  Proteasome inhibitor-induced cyclooxygenase-2 expression in Raw264.7 cells is potentiated by inhibition of c-Jun N-terminal kinase activation.

Authors:  Kyung Jin Woo; Jong-Wook Park; Taeg Kyu Kwon
Journal:  Biochem Biophys Res Commun       Date:  2006-02-28       Impact factor: 3.575

View more
  11 in total

1.  Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis.

Authors:  Hannu T Toivonen; Annika Meinander; Tomoko Asaoka; Mia Westerlund; Frank Pettersson; Andrey Mikhailov; John E Eriksson; Henrik Saxén
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

2.  The novel Akt inhibitor API-1 induces c-FLIP degradation and synergizes with TRAIL to augment apoptosis independent of Akt inhibition.

Authors:  Bo Li; Hui Ren; Ping Yue; Mingwei Chen; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-16

3.  The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.

Authors:  Liqun Zhao; Ping Yue; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2011-09-13       Impact factor: 6.261

4.  Itch/AIP4-independent proteasomal degradation of cFLIP induced by the histone deacetylase inhibitor SAHA sensitizes breast tumour cells to TRAIL.

Authors:  Rosario Yerbes; Abelardo López-Rivas
Journal:  Invest New Drugs       Date:  2010-11-25       Impact factor: 3.850

5.  mTOR complex 2 is involved in regulation of Cbl-dependent c-FLIP degradation and sensitivity of TRAIL-induced apoptosis.

Authors:  Liqun Zhao; Ping Yue; Fadlo R Khuri; Shi-Yong Sun
Journal:  Cancer Res       Date:  2013-01-14       Impact factor: 12.701

6.  Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein.

Authors:  Rachel P Wilkie-Grantham; Shu-Ichi Matsuzawa; John C Reed
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

Review 7.  FLIP the Switch: Regulation of Apoptosis and Necroptosis by cFLIP.

Authors:  Yuichi Tsuchiya; Osamu Nakabayashi; Hiroyasu Nakano
Journal:  Int J Mol Sci       Date:  2015-12-18       Impact factor: 5.923

8.  The arginine methyltransferase PRMT5 and PRMT1 distinctly regulate the degradation of anti-apoptotic protein CFLARL in human lung cancer cells.

Authors:  Mingyue Li; Wentao An; Linyan Xu; Yidan Lin; Ling Su; Xiangguo Liu
Journal:  J Exp Clin Cancer Res       Date:  2019-02-08

9.  Down-regulation of cellular FLICE-inhibitory protein (Long Form) contributes to apoptosis induced by Hsp90 inhibition in human lung cancer cells.

Authors:  Qilin Wang; Wendong Sun; Xuexi Hao; Tianliang Li; Ling Su; Xiangguo Liu
Journal:  Cancer Cell Int       Date:  2012-12-21       Impact factor: 5.722

10.  The deubiquitinase Usp27x as a novel regulator of cFLIPL protein expression and sensitizer to death-receptor-induced apoptosis.

Authors:  Manuel Nico Dold; Xiulin Ng; Claudia Alber; Ian Edward Gentle; Georg Häcker; Arnim Weber
Journal:  Apoptosis       Date:  2022-01-19       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.